Core Insights - The international operations of Avanos Medical are crucial for assessing its financial resilience and growth prospects [1][2][3] Revenue Performance - The total revenue for Avanos Medical in the quarter was $167.5 million, reflecting a year-over-year increase of 0.8% [4] - Revenue from Europe, Middle East, and Africa accounted for 14.15% of total revenue, amounting to $23.7 million, which was a surprise increase of 3.4% compared to analyst expectations [5] - Asia Pacific and Latin America contributed $13 million, or 7.76% of total revenue, representing a surprise increase of 12.07% over expectations [6] Future Revenue Forecasts - For the current fiscal quarter, total revenue is anticipated to be $167.69 million, a decline of 2.3% year-over-year, with expected contributions of 13.9% from Europe, Middle East, and Africa and 7.1% from Asia Pacific and Latin America [7] - The forecast for total revenue for the entire year is $677.36 million, a reduction of 1.5% from the previous year, with expected contributions of 13.8% from Europe, Middle East, and Africa and 7.1% from Asia Pacific and Latin America [8] Market Dynamics - Avanos Medical's reliance on international markets presents both opportunities and challenges, making it essential to track international revenue trends for future projections [9] - Financial analysts are closely monitoring these developments to refine earnings estimations, influenced by various factors including local market status [10]
Avanos Medical (AVNS) International Revenue in Focus: Trends and Expectations